Literature DB >> 3947485

Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.

A J Cowley, K Stainer, J M Rowley, J R Hampton.   

Abstract

To investigate the peripheral circulatory and respiratory abnormalities which occur in patients with heart failure, forearm and calf blood flow were measured before and after upright exercise, and respiratory gas exchange was measured during exercise in 26 patients with severe heart failure. Compared with a group of normal subjects the patients had reduced limb blood flow at rest and the response of limb blood flow to upright exercise was also abnormal. The increase in calf blood flow after exercise and the reduction in blood flow in the non-exercising forearm were both smaller in patients than in controls. There was a significant correlation between the maximum exercise duration of the patients and calf blood flow both after exercise and at rest. Compared with another group of control subjects the patients had a higher minute ventilation during exercise and a reduced oxygen consumption. The respiratory exchange ratio during exercise was also higher in patients than in controls. This suggests that there is early onset of anaerobic metabolism during exercise in patients with severe heart failure.

Entities:  

Mesh:

Year:  1986        PMID: 3947485      PMCID: PMC1232071          DOI: 10.1136/hrt.55.1.75

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

1.  Methods for the investigation of peripheral blood flow.

Authors:  A D GREENFIELD; R J WHITNEY; J F MOWBRAY
Journal:  Br Med Bull       Date:  1963-05       Impact factor: 4.291

2.  Impaired forearm oxygen consumption during static exercise in patients with congestive heart failure.

Authors:  J Longhurst; W Gifford; R Zelis
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

Review 3.  Cardiocirculatory responses to muscular exercise in congestive heart failure.

Authors:  D T Mason; R Zelis; J Longhurst; G Lee
Journal:  Prog Cardiovasc Dis       Date:  1977 May-Jun       Impact factor: 8.194

4.  Hydralazine in the management of left ventricular failure.

Authors:  D H Fitchett; J A Neto; C M Oakley; J F Goodwin
Journal:  Am J Cardiol       Date:  1979-08       Impact factor: 2.778

5.  Treadmill exercise in assessment of the functional capacity of patients with cardiac disease.

Authors:  J A Patterson; J Naughton; R J Pietras; R M Gunnar
Journal:  Am J Cardiol       Date:  1972-11       Impact factor: 2.778

6.  Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.

Authors:  S A Rubin; K Chatterjee; W W Parmley
Journal:  Circulation       Date:  1980-03       Impact factor: 29.690

7.  Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization.

Authors:  J A Franciosa; S Ziesche; M Wilen
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

8.  Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.

Authors:  D O Williams; W J Bommer; R R Miller; E A Amsterdam; D T Mason
Journal:  Am J Cardiol       Date:  1977-01       Impact factor: 2.778

9.  Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

Authors:  J A Franciosa; M Park; T B Levine
Journal:  Am J Cardiol       Date:  1981-01       Impact factor: 2.778

10.  Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.

Authors:  A H Maslowski; H Ikram; M G Nicholls; E A Espiner
Journal:  Lancet       Date:  1981-01-10       Impact factor: 79.321

View more
  13 in total

1.  Effects of food on the central and peripheral haemodynamic response to upright exercise in normal volunteers.

Authors:  J J Yi; L Fullwood; K Stainer; A J Cowley; J R Hampton
Journal:  Br Heart J       Date:  1990-01

2.  Relationship between the oxygen uptake during cardiopulmonary exercise testing and left ventricular function in patients with acute myocardial infarction.

Authors:  Hiroshi Maruoka; Kamon Imai; Akihito Kubota; Kazuhisa Inoue; Takayuki Taguchi; Ken Nishihara; Kazuhiko Hara; Osamu Fujinawa; Mitsutoshi Uematu; Akikazu Nakayama; Tadashi Mizorogi; Koukichi Ehara; Kazuho Hosoda
Journal:  J Jpn Phys Ther Assoc       Date:  2003

3.  Electrical muscle stimulation for chronic heart failure: an alternative tool for exercise training?

Authors:  Prithwish Banerjee
Journal:  Curr Heart Fail Rep       Date:  2010-06

Review 4.  Clinical and economic factors in the treatment of congestive heart failure.

Authors:  R Andrews; A J Cowley
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 5.  The treatment of heart failure--what next?

Authors:  R H Davies; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

6.  Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.

Authors:  A J Cowley; R D Wynne; K Stainer; L Fullwood; J M Rowley; J R Hampton
Journal:  BMJ       Date:  1988-07-16

7.  Abnormalities of skeletal muscle metabolism in patients with chronic heart failure: evidence that they are present at rest.

Authors:  R Andrews; J T Walsh; A Evans; S Curtis; A J Cowley
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

8.  Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.

Authors:  V Klauss; W Zwehl; H Mudra; R Huber; R Schmidt; M Scheininger; A Vogler; O Tschaidse; H A Dieterich; K Theisen
Journal:  Klin Wochenschr       Date:  1991-07-22

9.  The reproducibility of symptoms during a submaximal exercise test in chronic heart failure.

Authors:  S Grant; J McMurray; T Aitchison; T McDonagh; J Christie; A Davie; H J Dargie
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

Review 10.  Phosphodiesterase inhibitors. Do the risks outweight the benefits?

Authors:  R Andrews; A J Cowley
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.